Sign up Australia
Proactive Investors - Run By Investors For Investors

Roto-Gro International wins $2.25M order for cannabis growing system

The new order with EuroAg is worth over $2.25 million.
Roto-Gro International wins $2.25M order for cannabis growing system
Roto-Gro was admitted to the ASX last month

Canadian cannabis-tech company Roto-Gro International (ASX:RGI) has finalised an order with EuroAg Corporation for the supply of 240 Roto-Gro Units over a 12 month period.

The fully-automated Roto-Gro rotary hydroponic system (a method of growing plants without soil) can be used to produce high-quality medical cannabis at a competitive cost.

Roto-Gro’s shares were last trading 25.4% higher intra-day on Thursday, at $0.37.

Importantly, the new order with EuroAg will generate a minimum revenue of $2.25 million.

The agreement provides for EuroAg to order 240 units of the Roto-Gro 420B and/or 420C models, with the agreement renewable annually.

The Roto-Gro’s 420B Model is a complete rotary hydroponic vertical farming system.

The 420C has the same components as the 420B, with the addition of Roto-Gro’s proprietary software system that monitors various elements of the plant growth cycle.

The Roto-Gro System was designed and manufactured in Canada in late 2006 and has undergone continuous improvement since that date.

Between 2007 and 2012, about 600 units have been sold worldwide by Canadian distributor NutriLife Products.

Roto-Gro International was admitted to the ASX last month and has become the latest player to join the list of cannabis based companies on the ASX.

Roto-Gro is capitalising on the immediate opportunity in the rapidly expanding lawful medical cannabis market, with a focus on North America, Europe and Australia.

Australia legalised medical cannabis on 1 November 2016.

The new market in Australia is a significant opportunity for peripheral industries, specifically those that help grow, extract and distribute cannabis products.

View full RGI profile View Profile

Roto-Gro International Ltd Timeline

Related Articles

PreveCeutical Medical bidding to be big player in preventive healthcare
October 11 2017
Van Deventer aims to grow the firm's valuation from its current $40mln market cap to $1bn plus in the next few years
blood_56ceb82789b61.jpg
December 15 2016
The company's nominated adviser said a partnership deal should be signed by the end of 2016
Cellmid's Maria Halasz with investors at Proactive's CEO Sessions
October 06 2017
Maria Halasz discussed rapidly growing hair care sales at Proactive's CEO Sessions.

No investment advice

The information on this Site is of a general nature only. It does not take your specific needs or circumstances into consideration, so you should look at your own financial position, objectives and requirements and seek financial advice before making any financial decisions. You acknowledge and understand that neither the Company, its related bodies corporate, the information providers or their affiliates will advise you personally about the nature, potential value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter. You should read our FSG and any other relevant disclosure documents and if necessary seek persona advice prior to making any investment decision.

You understand and agree that no Content (as defined below) published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person.

You understand that in certain circumstances the Company, its related bodies corporate, the information providers or their affiliates may have received, or be entitled to receive, financial or other consideration in connection with promoting, and providing information about, certain entities on the Site and in communications otherwise provided to you.

You understand that price and other data is supplied by sources believed to be reliable, that the calculations herein are made using such data, and that neither such data nor such calculations are guaranteed by these sources, the Company, the information providers or any other person or entity, and may not be complete or accurate. From time to time, reference may be made in our marketing materials to prior articles and opinions we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.

Before you act on any general advice we provide, please consider whether it is appropriate for your personal circumstances.

© Proactive Investors 2017

Proactive Investors Australia PTY LTD ACN:132787654 ABN:19132787654.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use